APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amphetamine Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Amphetamine Drug Market Analysis and Forecast 2026-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchAmphetamine Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Amphetamine Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Amphetamine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amphetamine Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Amphetamine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Amphetamine Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Amphetamine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Amphetamine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Amphetamine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Amphetamine Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Amphetamine Drug include Novartis, Eli Lilly, Pfizer, GSK, Purdue Pharma and Hisamitsu Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Amphetamine Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Amphetamine Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Amphetamine Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amphetamine Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Amphetamine Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Amphetamine Drug sales, projected growth trends, production technology, application and end-user industry.

Amphetamine Drug Segment by Company

Novartis

Eli Lilly

Pfizer

GSK

Purdue Pharma

Hisamitsu Pharmaceutical

Amphetamine Drug Segment by Type

Adult

Children

Amphetamine Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

Amphetamine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amphetamine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amphetamine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amphetamine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Amphetamine Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Amphetamine Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amphetamine Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amphetamine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adult Major Manufacturers Table 3. Children Major Manufacturers Table 4. Global Amphetamine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Hospital Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Amphetamine Drug Industry Trends Table 9. Amphetamine Drug Industry Drivers Table 10. Amphetamine Drug Industry Opportunities and Challenges Table 11. Amphetamine Drug Industry Restraints Table 12. Global Amphetamine Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Amphetamine Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Amphetamine Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Amphetamine Drug Revenue Market Share by Region (2021-2026) Table 16. Global Amphetamine Drug Revenue Market Share by Region (2027-2032) Table 17. Global Amphetamine Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Amphetamine Drug Sales by Region (2021-2026) & (K Units) Table 19. Global Amphetamine Drug Sales by Region (2027-2032) & (K Units) Table 20. Global Amphetamine Drug Sales Market Share by Region (2021-2026) Table 21. Global Amphetamine Drug Sales Market Share by Region (2027-2032) Table 22. Global Amphetamine Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Amphetamine Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Amphetamine Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Amphetamine Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Amphetamine Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Amphetamine Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Amphetamine Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Amphetamine Drug Manufacturers, Product Type & Application Table 30. Global Amphetamine Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Amphetamine Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Amphetamine Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Amphetamine Drug Revenue Market Share by Type (2021-2026) Table 37. Global Amphetamine Drug Revenue Market Share by Type (2027-2032) Table 38. Global Amphetamine Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 40. Global Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 41. Global Amphetamine Drug Sales Market Share by Type (2021-2026) Table 42. Global Amphetamine Drug Sales Market Share by Type (2027-2032) Table 43. Global Amphetamine Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Amphetamine Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Amphetamine Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Amphetamine Drug Revenue Market Share by Application (2021-2026) Table 49. Global Amphetamine Drug Revenue Market Share by Application (2027-2032) Table 50. Global Amphetamine Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 53. Global Amphetamine Drug Sales Market Share by Application (2021-2026) Table 54. Global Amphetamine Drug Sales Market Share by Application (2027-2032) Table 55. Global Amphetamine Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amphetamine Drug Price by Application (2027-2032) & (US$/Unit) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Novartis Amphetamine Drug Product Portfolio Table 61. Novartis Recent Development Table 62. Eli Lilly Company Information Table 63. Eli Lilly Business Overview Table 64. Eli Lilly Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Eli Lilly Amphetamine Drug Product Portfolio Table 66. Eli Lilly Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pfizer Amphetamine Drug Product Portfolio Table 71. Pfizer Recent Development Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GSK Amphetamine Drug Product Portfolio Table 76. GSK Recent Development Table 77. Purdue Pharma Company Information Table 78. Purdue Pharma Business Overview Table 79. Purdue Pharma Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Purdue Pharma Amphetamine Drug Product Portfolio Table 81. Purdue Pharma Recent Development Table 82. Hisamitsu Pharmaceutical Company Information Table 83. Hisamitsu Pharmaceutical Business Overview Table 84. Hisamitsu Pharmaceutical Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio Table 86. Hisamitsu Pharmaceutical Recent Development Table 87. North America Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 90. North America Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 91. North America Amphetamine Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Amphetamine Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 96. North America Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 97. North America Amphetamine Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Amphetamine Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Amphetamine Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Amphetamine Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 104. North America Amphetamine Drug Sales by Country (2027-2032) & (K Units) Table 105. North America Amphetamine Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Amphetamine Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 108. Canada Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 109. Europe Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 112. Europe Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 113. Europe Amphetamine Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Amphetamine Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 118. Europe Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 119. Europe Amphetamine Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Amphetamine Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Amphetamine Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Amphetamine Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 126. Europe Amphetamine Drug Sales by Country (2027-2032) & (K Units) Table 127. Europe Amphetamine Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Amphetamine Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 130. France Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 131. U.K. Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 132. Italy Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 134. China Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. China Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. China Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 137. China Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 138. China Amphetamine Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Amphetamine Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 141. China Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 142. China Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 143. China Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 144. China Amphetamine Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Amphetamine Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 149. Asia Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 150. Asia Amphetamine Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Amphetamine Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 155. Asia Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 156. Asia Amphetamine Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Amphetamine Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Amphetamine Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Amphetamine Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 163. Asia Amphetamine Drug Sales by Country (2027-2032) & (K Units) Table 164. Asia Amphetamine Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Amphetamine Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 167. South Korea Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 168. India Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 169. Australia Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Amphetamine Drug Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Amphetamine Drug Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Amphetamine Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Amphetamine Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Amphetamine Drug Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Amphetamine Drug Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Amphetamine Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Amphetamine Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Amphetamine Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Amphetamine Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Amphetamine Drug Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Amphetamine Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Amphetamine Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 193. Argentina Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 194. Chile Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 195. Colombia Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 196. Peru Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 198. Israel Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 199. UAE Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 200. Turkey Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 201. Iran Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 202. Egypt Amphetamine Drug Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Amphetamine Drug Distributors List Table 206. Amphetamine Drug Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Amphetamine Drug Image Figure 2. Global Amphetamine Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amphetamine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adult Image Figure 5. Children Image Figure 6. Global Amphetamine Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Amphetamine Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Hospital Pharmacy Image Figure 10. Other Image Figure 11. Global Amphetamine Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Amphetamine Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Amphetamine Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Amphetamine Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Amphetamine Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Amphetamine Drug Sales (2021-2032) & (K Units) Figure 17. Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Amphetamine Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Amphetamine Drug Sales YoY (2021-2032) & (K Units) Figure 20. Europe Amphetamine Drug Sales YoY (2021-2032) & (K Units) Figure 21. China Amphetamine Drug Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Amphetamine Drug Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Amphetamine Drug Sales YoY (2021-2032) & (K Units) Figure 24. Global Amphetamine Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Amphetamine Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Amphetamine Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Amphetamine Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Amphetamine Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Amphetamine Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Amphetamine Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Amphetamine Drug Sales Market Share by Type (2021-2032) Figure 33. Global Amphetamine Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Amphetamine Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Amphetamine Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Amphetamine Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Amphetamine Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Amphetamine Drug Sales Market Share by Application (2021-2032) Figure 39. North America Amphetamine Drug Revenue Share by Type (2021-2032) Figure 40. North America Amphetamine Drug Sales Share by Type (2021-2032) Figure 41. North America Amphetamine Drug Revenue Share by Application (2021-2032) Figure 42. North America Amphetamine Drug Sales Share by Application (2021-2032) Figure 43. North America Amphetamine Drug Revenue Share by Country (2021-2032) Figure 44. North America Amphetamine Drug Sales Share by Country (2021-2032) Figure 45. Europe Amphetamine Drug Revenue Share by Type (2021-2032) Figure 46. Europe Amphetamine Drug Sales Share by Type (2021-2032) Figure 47. Europe Amphetamine Drug Revenue Share by Application (2021-2032) Figure 48. Europe Amphetamine Drug Sales Share by Application (2021-2032) Figure 49. Europe Amphetamine Drug Revenue Share by Country (2021-2032) Figure 50. Europe Amphetamine Drug Sales Share by Country (2021-2032) Figure 51. China Amphetamine Drug Revenue Share by Type (2021-2032) Figure 52. China Amphetamine Drug Sales Share by Type (2021-2032) Figure 53. China Amphetamine Drug Revenue Share by Application (2021-2032) Figure 54. China Amphetamine Drug Sales Share by Application (2021-2032) Figure 55. Asia Amphetamine Drug Revenue Share by Type (2021-2032) Figure 56. Asia Amphetamine Drug Sales Share by Type (2021-2032) Figure 57. Asia Amphetamine Drug Revenue Share by Application (2021-2032) Figure 58. Asia Amphetamine Drug Sales Share by Application (2021-2032) Figure 59. Asia Amphetamine Drug Revenue Share by Country (2021-2032) Figure 60. Asia Amphetamine Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Amphetamine Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Amphetamine Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Amphetamine Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Amphetamine Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Amphetamine Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Amphetamine Drug Sales Share by Country (2021-2032) Figure 67. Amphetamine Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Amphetamine Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Children
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Novartis
  • Eli Lilly
  • Pfizer
  • GSK
  • Purdue Pharma
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Amphetamine Drug Market by Type
  3. 1.2.1 Global Amphetamine Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adult
  5. 1.2.3 Children
  6. 1.3 Amphetamine Drug Market by Application
  7. 1.3.1 Global Amphetamine Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Hospital Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Amphetamine Drug Market Dynamics
  1. 2.1 Amphetamine Drug Industry Trends
  2. 2.2 Amphetamine Drug Industry Drivers
  3. 2.3 Amphetamine Drug Industry Opportunities and Challenges
  4. 2.4 Amphetamine Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Amphetamine Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Amphetamine Drug Revenue by Region
  3. 3.2.1 Global Amphetamine Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Amphetamine Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Amphetamine Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Amphetamine Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Amphetamine Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Amphetamine Drug Sales by Region
  9. 3.4.1 Global Amphetamine Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Amphetamine Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Amphetamine Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Amphetamine Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Amphetamine Drug Revenue by Manufacturers
  2. 4.1.1 Global Amphetamine Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Amphetamine Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Amphetamine Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Amphetamine Drug Sales by Manufacturers
  6. 4.2.1 Global Amphetamine Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Amphetamine Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Amphetamine Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Amphetamine Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Amphetamine Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Amphetamine Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Amphetamine Drug Manufacturers, Product Type & Application
  13. 4.7 Global Amphetamine Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Amphetamine Drug Market CR5 and HHI
  16. 4.8.2 2025 Amphetamine Drug Tier 1, Tier 2, and Tier 3
5 Amphetamine Drug Market by Type
  1. 5.1 Global Amphetamine Drug Revenue by Type
  2. 5.1.1 Global Amphetamine Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Amphetamine Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Amphetamine Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Amphetamine Drug Sales by Type
  6. 5.2.1 Global Amphetamine Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amphetamine Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Amphetamine Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Amphetamine Drug Price by Type
6 Amphetamine Drug Market by Application
  1. 6.1 Global Amphetamine Drug Revenue by Application
  2. 6.1.1 Global Amphetamine Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Amphetamine Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Amphetamine Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Amphetamine Drug Sales by Application
  6. 6.2.1 Global Amphetamine Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Amphetamine Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Amphetamine Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Amphetamine Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Amphetamine Drug Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Eli Lilly
  8. 7.2.1 Eli Lilly Company Information
  9. 7.2.2 Eli Lilly Business Overview
  10. 7.2.3 Eli Lilly Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly Amphetamine Drug Product Portfolio
  12. 7.2.5 Eli Lilly Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Amphetamine Drug Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GSK Amphetamine Drug Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 Purdue Pharma
  26. 7.5.1 Purdue Pharma Company Information
  27. 7.5.2 Purdue Pharma Business Overview
  28. 7.5.3 Purdue Pharma Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Purdue Pharma Amphetamine Drug Product Portfolio
  30. 7.5.5 Purdue Pharma Recent Developments
  31. 7.6 Hisamitsu Pharmaceutical
  32. 7.6.1 Hisamitsu Pharmaceutical Company Information
  33. 7.6.2 Hisamitsu Pharmaceutical Business Overview
  34. 7.6.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
  36. 7.6.5 Hisamitsu Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Amphetamine Drug Market Size by Type
  2. 8.1.1 North America Amphetamine Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Amphetamine Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Amphetamine Drug Price by Type (2021-2032)
  5. 8.2 North America Amphetamine Drug Market Size by Application
  6. 8.2.1 North America Amphetamine Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Amphetamine Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Amphetamine Drug Price by Application (2021-2032)
  9. 8.3 North America Amphetamine Drug Market Size by Country
  10. 8.3.1 North America Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Amphetamine Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Amphetamine Drug Market Size by Type
  2. 9.1.1 Europe Amphetamine Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Amphetamine Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Amphetamine Drug Price by Type (2021-2032)
  5. 9.2 Europe Amphetamine Drug Market Size by Application
  6. 9.2.1 Europe Amphetamine Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Amphetamine Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Amphetamine Drug Price by Application (2021-2032)
  9. 9.3 Europe Amphetamine Drug Market Size by Country
  10. 9.3.1 Europe Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Amphetamine Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Amphetamine Drug Market Size by Type
  2. 10.1.1 China Amphetamine Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Amphetamine Drug Sales by Type (2021-2032)
  4. 10.1.3 China Amphetamine Drug Price by Type (2021-2032)
  5. 10.2 China Amphetamine Drug Market Size by Application
  6. 10.2.1 China Amphetamine Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Amphetamine Drug Sales by Application (2021-2032)
  8. 10.2.3 China Amphetamine Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Amphetamine Drug Market Size by Type
  2. 11.1.1 Asia Amphetamine Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Amphetamine Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Amphetamine Drug Price by Type (2021-2032)
  5. 11.2 Asia Amphetamine Drug Market Size by Application
  6. 11.2.1 Asia Amphetamine Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Amphetamine Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Amphetamine Drug Price by Application (2021-2032)
  9. 11.3 Asia Amphetamine Drug Market Size by Country
  10. 11.3.1 Asia Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Amphetamine Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Amphetamine Drug Market Size by Type
  2. 12.1.1 SAMEA Amphetamine Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Amphetamine Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Amphetamine Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Amphetamine Drug Market Size by Application
  6. 12.2.1 SAMEA Amphetamine Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Amphetamine Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Amphetamine Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Amphetamine Drug Market Size by Country
  10. 12.3.1 SAMEA Amphetamine Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Amphetamine Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Amphetamine Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Amphetamine Drug Value Chain Analysis
  2. 13.1.1 Amphetamine Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Amphetamine Drug Production Mode & Process
  6. 13.2 Amphetamine Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Amphetamine Drug Distributors
  9. 13.2.3 Amphetamine Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst